Newsroom

Newsroom

Nucleus image.

Press Release

December 11, 2020
Huntsworth, a Clayton, Dubilier & Rice portfolio company, has completed the previously announced acquisition of Nucleus Global, creating a global leader in Medical Communications. The terms of the transaction were not disclosed. The combination...
Nucleus image.

Press Release

December 11, 2020
Huntsworth, a Clayton, Dubilier & Rice portfolio company, has completed the previously announced acquisition of Nucleus Global, creating a global leader in Medical Communications. The terms of the transaction were not disclosed. The combination...
ILPA

Press Release

December 9, 2020
CD&R is pleased to support the newly launched Diversity in Action initiative of the Institutional Limited Partners Association (ILPA) as a founding signatory. The initiative aligns with CD&R’s commitment to advance diversity, equity, and...
Nucleus Global Logo.

Press Release

November 6, 2020
Huntsworth, a Clayton, Dubilier & Rice portfolio company, has announced an agreement to acquire Nucleus Global from its founder, Stephen Cameron. The combination will create a global leader in the fast growing medical communications space and...
Nucleus Global Logo.

Press Release

November 6, 2020
Huntsworth, a Clayton, Dubilier & Rice portfolio company, has announced an agreement to acquire Nucleus Global from its founder, Stephen Cameron. The combination will create a global leader in the fast growing medical communications space and...
Rick Schnall

Media Coverage

October 27, 2020
Private equity can offer more than just capital--this firm has a long history of making operational improvements. 
Inc Private Equity 50 logo.

Media Coverage

October 27, 2020
Inc. Magazine published its second annual list of private equity firms known for being good partners to entrepreneurs. CD&R is proud to be recognized for its work with family and founder-led companies and included on the list.
Epicor image.

Press Release

October 14, 2020
Clayton, Dubilier & Rice today announced the closing of CD&R funds’ acquisition of Epicor, a global provider of industry-specific enterprise software to industrial sectors. The transaction is valued at $4.7 billion. Epicor is a leading...
Mr. Bango photo.

Events

September 24, 2020
CD&R’s Operating Partner Vindi Banga served as a discussion leader at the World Economic Forum’s Sustainable Development Impact Summit, where he outlined the long-term value creation case for engagement on environmental, social and governance (...
Epicor logo.

Press Release

August 31, 2020
Clayton, Dubilier & Rice, KKR, and Epicor Software Corporation today announced a definitive agreement whereby CD&R funds will acquire Epicor, a global provider of industry-specific enterprise software to industrial-focused sectors, from...
PEI Keynote Interview

Media Coverage

March 1, 2022
Strong partnerships are critical to developing businesses at scale throughout key markets in Europe, say Marco Herbst, Greg Laï, Christian Rochat and Eric Rouzier at Clayton, Dubilier & Rice
Call In Podcast Logo.

Media Coverage

February 24, 2022
Episode 10 of the Call In podcast features a conversation with Julian Francis, President and CEO of Beacon Building Products – the largest publicly traded distributor of roofing materials and complementary building products in the U.S. and Canada...
Vera Whole Health Logo.

Press Release

February 17, 2022
Vera Whole Health, Inc. ("Vera") announced today that it has successfully completed its previously announced acquisition of Castlight Health, Inc. ("Castlight") at a price of $2.05 per share, net to the seller, in cash, without interest and subject...
Andrea Peiro

Press Release

February 9, 2022
Clayton, Dubilier & Rice announced the appointment of Andrea Peiro, an experienced technology professional and successful entrepreneur, as an Operating Principal. In his new role, Mr. Peiro will be engaged in evaluating investments and help...
Hand holding a seedling.

Perspectives

February 7, 2022
The conversation about private equity and environmental, social and corporate governance (ESG) has been largely around reporting guidelines and metrics. We believe private equity is well-positioned to drive and scale ESG best practices. The...
Anand Shah, M.D.

Press Release

February 3, 2022
Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration (“FDA”) Deputy Commissioner for Medical and Scientific Affairs, as an Operating Advisor to CD&R funds. Dr. Shah will work with CD&R’s...
Vera Whole Health and Castlight Health logos

Press Release

January 5, 2022
Castlight Health, Inc. (“Castlight”) (NYSE: CSLT), a leading healthcare data and navigation company, and Vera Whole Health, Inc. (“Vera”), a pioneer in advanced primary care, today jointly announced an agreement under which the companies will...
Jon Selib Headshot

Press Release

December 21, 2021
Clayton, Dubilier & Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy & Public Affairs at Pfizer, as Managing Director and Global External Affairs Leader. In his new role, which will take effect...
Belron logo

Press Release

December 17, 2021
Clayton, Dubilier & Rice Fund X today announced the sale of its investment in Belron, a worldwide leader in vehicle glass repair and replacement. The two-part transaction included the sale of approximately 39% of CD&R Fund X’s stake to funds...
Gordon Riske

Press Release

December 13, 2021
Clayton, Dubilier & Rice announced today that Gordon Riske will be engaged as an Operating Advisor to CD&R funds effective January 1, 2022 after he steps down as Chief Executive Officer of KION GROUP AG, a global provider of materials...
Certain persons quoted in certain news items are advisors to CD&R’s funds or executives, employees, directors or persons serving in similar capacities in CD&R’s funds’ portfolio companies, or other persons or organizations who have or may in the future have business or other relationships with CD&R or its funds. Such relationships and any compensation associated with them create a conflict of interest, as the relationship and/or the compensation incentivizes such person to endorse CD&R or its funds.